(Q43725989)

26 November 2017

title

Progressive brain dysfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide (English)

1 reference

26 November 2017

Nakamura S

1

1 reference

26 November 2017

Murayama N

2

1 reference

26 November 2017

Noshita T

3

1 reference

26 November 2017

Annoura H

4

1 reference

26 November 2017

Ohno T

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

912

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

128-136

1 reference

Beta-amyloid peptides as direct cholinergic neuromodulators: a missing link?

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

The neurochemical and behavioral effects of beta-amyloid peptide(25-35)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Implants containing beta-amyloid protein are not neurotoxic to young and old rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Selective loss of central cholinergic neurons in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

A rapid radiochemical method for the determination of choline acetyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Long-term changes in the aggregation state and toxic effects of beta-amyloid injected into the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Cholinotoxic effects of beta-amyloid (1-42) peptide on cortical projections of the rat nucleus basalis magnocellularis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Beta-amyloid(Phe(SO3H)24)25-35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Identification of sodium-dependent, high-affinity choline uptake sites in rat brain with [3H]hemicholinium-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Amyloid plaque core protein in Alzheimer disease and Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Spatial localization does not require the presence of local cues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Reduction in somatostatin and substance P levels and choline acetyltransferase activity in the cortex and hippocampus of the rat after chronic intracerebroventricular infusion of beta-amyloid (1-40).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Task-dependent memory loss and recovery following unilateral nucleus basalis lesion: behavioral and neurochemical correlation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

beta-Amyloid protein-induced Alzheimer's disease animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Synthetic amyloid beta-protein fails to produce specific neurotoxicity in monkey cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Intracerebral beta-amyloid(25-35) produces tissue damage: is it neurotoxic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

The molecular pathology of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Presynaptic cholinergic dysfunction in patients with dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Measurement of protein using bicinchoninic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Behavioral and neuropathologic changes induced by central injection of carboxyl-terminal fragment of beta-amyloid precursor protein in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Failure of beta-amyloid protein fragment 25-35 to cause hippocampal damage in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902704-4

10.1016/S0006-8993(01)02704-4

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference